Sort
141,003 grants matching “cytokine”
Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)
$713,937Usha Sethuraman · Central Michigan University · R33 · FY2023 · HD
Photobiomodulation for the management of Temporomandibular disorder pain
$713,935Margarete C Ribeiro-Dasilva · University Of Florida · UH3 · FY2023 · DE
ETS-family Transcription Factor Mediated Control of Pulmonary Inflammation Induced by Influenza Viruses
$713,913Nicholas S Heaton · Duke University · R01 · FY2024 · AI
Bisphenol A and Children's Growth & Development
$713,880Kim G. Harley · University Of California Berkeley · RC2 · FY2010 · ES
New strategies for treating septic vasculopathy, inflammation and thrombosis
$713,873Xiaoping Du · University Of Illinois At Chicago · R01 · FY2018 · HL
New strategies for treating septic vasculopathy, inflammation and thrombosis
$713,873Xiaoping Du · University Of Illinois At Chicago · R01 · FY2017 · HL
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
$713,861David Baker · University Of Washington · R01 · FY2022 · AI
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$713,845Shirit Einav · Stanford University · R01 · FY2023 · AI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$713,830Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2024 · AI
Mechanism of Endotoxin's Effect On Allergy Risk
$713,713Henry Ford Health System · R01 · FY2005 · AI
Role of eosinophil cationic proteins in cardiac hypertrophy
$713,655Peter Libby · Brigham And Women'S Hospital · R01 · FY2025 · HL
Role of eosinophil cationic proteins in cardiac hypertrophy
$713,654Peter Libby · Brigham And Women'S Hospital · R01 · FY2023 · HL
Effect of sex hormones on HIV infection of cervical and rectal mucosal tissue
$713,593Natalia Teleshova · Population Council · R01 · FY2017 · AI
New Molecular Targets in Pulmonary Fibrosis
$713,582University Of Pittsburgh At Pittsburgh · R01 · FY2003 · HL
Antagonism of Alpha2A-Adrenoceptor: A Novel Anti-Sepsis Therapy
$713,482Xiaoling Qiang · Therasource, Llc · R44 · FY2011 · AI
Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
$713,464Thorsten M Leucker · Johns Hopkins University · R01 · FY2025 · HL
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$713,430Craig R Cohen · University Of California, San Francisco · R01 · FY2020 · HD
Risk and Resilience in Urban Black American Acute Trauma Survivors
$713,411Christine L Larson · University Of Wisconsin Milwaukee · R01 · FY2024 · MH
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$713,382Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2021 · AI
Depression & CHD: Cellular-Molecular Mechanisms
$713,358Edward Carlos Suarez · Duke University · R01 · FY2013 · HL
Improving the Safety of Genome Editing With Human Kidney Organoids
$713,345Benjamin Solomon Freedman · University Of Washington · U01 · FY2019 · EB
Role of inflammation, innate resistance, and immunity in carcinogenesis
$713,277Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
$713,270Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2021 · AI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
$713,270Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2023 · AI
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
$713,270Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2022 · AI